Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
04/2003
04/23/2003CN1106383C Estrogenic agents
04/23/2003CA2403307A1 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
04/22/2003US6552216 Molecular model for VLA-4 inhibitors
04/22/2003US6552193 Chloropyrimidine intermediates
04/22/2003US6552183 Moncyclic L-nucleosides analogs
04/22/2003US6552073 Compounds and methods of treating cell proliferative diseases
04/22/2003US6552067 EP4 receptor selective agonists in the treatment of osteoporosis
04/22/2003US6552065 Antiproliferative agents
04/22/2003US6552054 Chromone derivatives, process for the preparation of the same and uses thereof
04/22/2003US6552030 Inhibit human factor Xa; treating thrombotic activity; 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4-((2-(1,2 -dihydoxyethyl)-4-hydroxy-5-ethoxytetrahydrofuran-3-yl)oxy)-pyridin-2 -yl)oxy)4-hydroxybenzamidine
04/22/2003CA2239187C Inhibitors of farnesyl protein transferase
04/17/2003WO2003031440A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
04/17/2003WO2003031439A1 Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole
04/17/2003WO2003031436A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
04/17/2003WO2003031432A1 Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
04/17/2003WO2003031414A1 Novel heterocyclic compound and anti-inflammatory agent
04/17/2003WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto
04/17/2003WO2003031403A2 Process to produce derivatives from uk-2a derivatives
04/17/2003WO2003031397A1 Acylsulfonamides as inhibitors of steroid sulfatase
04/17/2003WO2003031376A1 Solid phase synthesis of substituted 1,5-benzodiazepine-2-one and 1,5-benzothiazepine-2-one
04/17/2003WO2003030937A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
04/17/2003WO2003030909A1 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
04/17/2003WO2003030902A1 Imidazole derivates as anti-inflammatory agents
04/17/2003WO2003030898A1 Modulators of ccr5 chemokine receptor activity
04/17/2003WO2003030897A1 Pyrrolidinone derivatives
04/17/2003WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
04/17/2003WO2003007887A3 Substituted imidazoles as cannabinoid receptor modulators
04/17/2003WO2003005999A3 Methods of treating cytokine mediated diseases
04/17/2003WO2002032865A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
04/17/2003WO2001094341A9 Quinazoline derivatives for the treatment of tumours
04/17/2003WO2001017965A3 Cyanopiperidines as pesticides
04/17/2003WO2000010990A3 Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
04/17/2003WO1999064401A3 Imidazolyl derivatives and their use as somatostatin receptor ligands
04/17/2003US20030073852 Anticancer agents
04/17/2003US20030073850 Incontinence; nasal congestion
04/17/2003US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
04/17/2003US20030073842 Psychological disorders; hypotensive agents
04/17/2003US20030073839 Compounds useful for preparation of Beta-3 adrenoreceptor agonist
04/17/2003US20030073838 3-alkyl-3-phenyl-piperidines
04/17/2003US20030073836 Heteroarylcarboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
04/17/2003US20030073736 5-Substituted-3(2H)-furanones useful for inhibition of farnesyl-protein transferase
04/17/2003US20030073731 Alkylation therapy; anticancer agent
04/17/2003US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease
04/17/2003US20030073704 Analgesics; antidiabetic agents; antiinflamamtory agents
04/17/2003US20030073701 Succinoylamino heterocycles as inhibitors of a beta protein production
04/17/2003US20030073692 Anticancer agents; viricides; Alzheimer's diseases
04/17/2003US20030073687 Alzheimer's disease; anticancer agents; antidiabetic agents
04/17/2003US20030073686 Anticarcinogenic agents
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/17/2003US20030073205 Production of polyketides
04/17/2003CA2463198A1 Pyrrolidinone derivatives
04/17/2003CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
04/17/2003CA2458456A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
04/17/2003CA2458453A1 Acylsulfonamides as inhibitors of steroid sulfatase
04/16/2003EP1302470A1 Lipid-rich plaque inhibitors
04/16/2003EP1302463A1 Medicine comprising dicyanopyridine derivative
04/16/2003EP1302462A1 Sulfone derivatives, process for their production and use thereof
04/16/2003EP1302461A1 Tnf-alpha production inhibitors
04/16/2003EP1301508A1 Novel processes for the preparation of 4-phenylpiperidine derivatives
04/16/2003EP1301503A1 Coumarin derivatives with comt inhibiting activity
04/16/2003EP1301502A1 Novel compounds and their use as glycine transport inhibitors
04/16/2003EP1301493A2 Heterocycle carboxamides as antiviral agents
04/16/2003EP1301491A1 Process for the preparation of 4,6-dimethoxy-2-(methylsulfonyl)-1,3-pyrimidine
04/16/2003EP1301487A2 Viral polymerase inhibitors
04/16/2003EP1301484A2 Capsaicin receptor ligands
04/16/2003EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists
04/16/2003EP1301480A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
04/16/2003EP1255737A4 Process for preparing a 1-substituted 5-hydroxymethyl imidazole
04/16/2003EP1181017B1 Metalloprotease inhibitors
04/16/2003EP1029860B1 Benzofuran derivatives
04/16/2003EP0765160B1 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions
04/16/2003EP0674634B1 Process for preparing substituted 1,3-oxathiolanes with antiviral properties
04/16/2003CN1411460A Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
04/16/2003CN1411457A Substituted pyrroles
04/16/2003CN1411445A Method for preparing 3-hydroxypicolinic acid derivatives
04/16/2003CN1105717C Substituted sulphonylamino (thio) carbony/compounds
04/16/2003CN1105710C Substituted diazacyclo hexandi (thi) ones
04/16/2003CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors
04/16/2003CN1105560C Use of efaroxan for producing medicine for treating huntington disease
04/15/2003US6548548 Cardiovascular disorders; anticholesterol agents
04/15/2003US6548546 HIV integrase inhibitors
04/15/2003US6548530 Antitumor drugs incorporate the 1,2,9,9a-tetrahydrocyclopropa(c)benz(e)indol-4-one (CBI) alkylation subunit; cytotoxic activity
04/15/2003US6548529 Heterocyclic containing biphenyl aP2 inhibitors and method
04/15/2003US6548502 Preventing disorder selected from pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction such as drug and alcohol and sex in a mammals by administering pyrido(1,2-a) pyrazine derivatives
04/15/2003US6548499 Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
04/15/2003US6548451 Use of derivatives of 2-oxopyrrole as crop protection agents and novel 2-oxopyrroles
04/15/2003US6548293 Enzymatic process for the resolution of enantiomeric mixtures of β-lactams
04/15/2003US6547841 Reacting sterically hindered nitroxyl compound with diazonium salt of aromatic amine compound in presence of transition metal catalyst
04/15/2003CA2169737C Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
04/15/2003CA2053208C Hydroxyalkylquinoline ether acids as leukotriene antagonists
04/15/2003CA2037975C 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors
04/10/2003WO2003029238A1 Chroman derivatives as 5-hydroxytryptamine-6 ligands
04/10/2003WO2003029227A1 Adhesion promoters containing benzotriazoles
04/10/2003WO2003029223A1 Substituted n-(1,4,5,6-tetrahydrocyclopentapyrazol-3-yl) derivatives and the use of the same for the treatment of cancer
04/10/2003WO2003029215A1 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders
04/10/2003WO2003029210A2 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
04/10/2003WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
04/10/2003WO2003028726A1 Quinoline derivatives as neuropeptide y antagonists
04/10/2003WO2003028721A2 Substituted benzimidazole compounds and their use for the treatment of cancer
04/10/2003WO2003028720A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
1 ... 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 ... 694